The visual field test is one of the most frequently ordered diagnostic tests in ophthalmology — with over 6 million performed annually in the US according to CMS utilization data. Most patients have no idea what it actually measures or why their doctor keeps ordering it at every visit.
Here’s what it does, what it costs, and when you genuinely need it.
What a Visual Field Test Actually Measures
Your visual field is the complete extent of what you can see — not just the sharp center, but the entire panorama including the periphery. Visual field testing (automated perimetry) measures how sensitive your retina is to light stimuli across that entire field.
It’s not testing how sharp your vision is (that’s visual acuity, measured with the eye chart). It’s testing whether your retina and visual pathways can detect light at each point in your visual field. Loss of sensitivity at specific locations — called scotomas — creates characteristic patterns that point to specific diseases.
The Humphrey Field Analyzer (HFA) is the dominant instrument in US ophthalmology practices. It presents brief flashes of light at hundreds of points across your visual field while you fixate on a central target and press a button each time you see a flash.
Test Patterns and When Each Is Used
| Test Pattern | Points Tested | Clinical Use |
|---|---|---|
| 24-2 (SITA-Standard or SITA-Fast) | 54 points within 24° | Glaucoma — the standard workhorse |
| 30-2 | 76 points within 30° | Broader glaucoma assessment, neurological |
| 10-2 | 68 points within 10° | Advanced glaucoma, macula-threatening disease |
| Esterman Binocular | Binocular field | Driving fitness assessment |
| Goldmann Kinetic | Full field, manual | Neurological, very advanced field loss |
The 24-2 is where most glaucoma monitoring starts. The 10-2 is used when central field loss is suspected or when glaucoma is advanced enough that the 24-2 shows extensive loss and you need better resolution of the remaining central field.
What the Printout Shows: Reading Your Own Results
Most patients get a stack of test results from their glaucoma appointments without understanding what they’re looking at. Key numbers:
MD (Mean Deviation): The average deviation from normal sensitivity across all test points. A normal result is near 0 dB. Values become more negative as field loss worsens — mild loss is -2 to -6 dB, moderate is -6 to -12 dB, severe is below -12 dB.
PSD (Pattern Standard Deviation): Measures how irregular the field is. High PSD means focal defects — characteristic of glaucoma. A field that’s uniformly dim (from media opacity like cataract) shows normal PSD with low MD.
GHT (Glaucoma Hemifield Test): A summary comparison of the upper and lower halves of the visual field. Reports as “Within Normal Limits,” “Borderline,” or “Outside Normal Limits.”
VFI (Visual Field Index): A percentage (0–100%) of normal field remaining. 100% = normal. Used to track rate of change over time.
Visual field testing is inherently variable. Patient fatigue, blinking at the wrong moment, poor fixation, and mild inattention all affect results. A single abnormal test is rarely diagnostic.
The AAO’s Preferred Practice Pattern for glaucoma recommends confirming any suspicious defect with repeat testing before making treatment decisions. For glaucoma monitoring, a minimum of 2 reliable tests per year over 2 years is often needed to estimate rate of progression accurately. More frequent testing (3–4 per year) gives a faster, more reliable estimate of how quickly the field is changing.
Cost by Setting
| Setting | Typical Cost Per Eye |
|---|---|
| Ophthalmology practice | $50–$150 per eye |
| Optometry practice | $75–$200 per eye |
| Neurology office (neuro-ophthalmology) | $100–$200 per eye |
| Hospital-based eye clinic | $100–$250 per eye |
| With Medicare (patient pays after 80% coverage) | $10–$30 per eye |
Tests are usually ordered bilaterally. A bilateral 24-2 at an ophthalmology office runs $100–$300 total without insurance; with Medicare after the 80% coverage, you typically pay $20–$60.
Medicare Coverage: What Qualifies
Medicare Part B covers visual field testing at 80% (after the annual deductible) for medically necessary indications. The most common qualifying conditions:
- Glaucoma diagnosis and monitoring (established or suspected)
- Neurological conditions affecting vision (stroke, pituitary tumor, multiple sclerosis)
- Optic nerve disease (optic neuritis, ischemic optic neuropathy)
- Diabetic retinopathy with vision changes
- Glaucoma screening for high-risk beneficiaries (free annually — no deductible or coinsurance)
High-risk beneficiaries for the free annual glaucoma screening include: diabetes mellitus patients, first-degree relatives of a glaucoma patient, African Americans age 50+, and Hispanic Americans age 65+.
How Often Do You Actually Need It
This depends entirely on your diagnosis and stability:
- No known eye disease: Not routinely needed; included in a comprehensive exam if the doctor suspects pathology
- Glaucoma suspect or ocular hypertension: Annually or every 6 months depending on risk factors
- Stable glaucoma: Every 6–12 months
- Progressive or advanced glaucoma: Every 3–4 months — faster testing reveals rate of change sooner, enabling earlier treatment adjustment
- Post-stroke or neurological condition: At initial evaluation, then per neurologist or neuro-ophthalmologist guidance
Visual field testing for driving is increasingly used. Some states require periodic visual field documentation for license renewal in patients with known visual field conditions. The Esterman Binocular test is designed specifically for this — it assesses the binocular field as a whole rather than each eye separately. If you’ve been diagnosed with a condition affecting your visual field, ask your ophthalmologist whether your state has reporting requirements that could affect your driver’s license.
Bottom Line
A visual field test costs $50–$200 per session, with Medicare patients paying $10–$60 out-of-pocket after coverage. It’s the essential functional measure for glaucoma monitoring — OCT tells you about structure, visual fields tell you about function, and you need both. Stable glaucoma patients typically get tested twice yearly; progressive disease warrants 3–4 times per year. One abnormal test doesn’t mean much — reproducible defects across multiple visits do. If your ophthalmologist orders it repeatedly, there’s a very good reason.
Frequently Asked Questions
A standard Humphrey 24-2 SITA-Standard test takes about 5–7 minutes per eye. Older protocols (full threshold) took 10–12 minutes per eye, but SITA algorithms have cut testing time roughly in half while maintaining accuracy. Patients sometimes find the test fatiguing — you're staring at a bowl-shaped screen while pressing a button every time you see a light flash. Blink normally, don't try to catch every possible stimulus, and take the test when you're alert rather than fatigued.
A field defect (scotoma) means reduced sensitivity in a part of your visual field. A single defect doesn't necessarily mean disease — fixation losses, patient fatigue, and eyelid drooping can all create false defects. Your ophthalmologist interprets results in context: the pattern matters enormously. Superior arcuate defects suggest glaucoma. Bitemporal hemianopia (loss of outer visual fields in both eyes) suggests a pituitary lesion. Homonymous hemianopia (loss of the same side in both eyes) suggests a cortical lesion. Reproducibility across multiple tests matters more than a single abnormal result.
Medicare Part B covers visual field testing when medically necessary — for example, for glaucoma diagnosis and monitoring, or for evaluation of neurological conditions affecting vision. For glaucoma screening specifically, Medicare covers one annual glaucoma screening exam (including visual field testing) for high-risk beneficiaries at no charge under the Medicare glaucoma screening benefit. Standard 80% Part B coverage applies for diagnostic testing ordered for established conditions.